L

Lixte Biotechnology Holdings

D
LIXT
USD
-0.175
(-9.7493%)
Market Closed
1,650.00
حجم التداول
الربح لكل سهم
-
العائد الربحي
-0.941860
P/E
3,643,849.80
حجم السوق
اليوم
-9.7493%
1 اسبوع
-23.944%
1 شهر
-10.989%
6 اشهر
-44.138%
12 اشهر
-48.243%
بداية السنة
-31.064%
كل الوقت
-95.703%

Title:
Lixte Biotechnology Holdings

Sector:
Healthcare
Industry:
Biotechnology
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. Itfocuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
هل تحتاج مساعدة او لديك استفسار؟